Emerging indications for TAVI in 2025

Discussants: F. Baslaib, R. Costa, T. Patterson, V. Veulemans

Anchorperson: M. Joner

Summary

Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.

Learning Objectives

To learn about emerging TAVI indications
To get updated on latest clinical trial outcomes for these indications
To get exposed to new technologies aimed at emerging TAVI indications

Presentations available when logged in:

Welcome and session objectives
Case 1 - An asymptomatic patient with severe degenerative aortic valve stenosis to be treated by TAVI
Evidence supporting the treatment of asymptomatic patients with severe aortic valve stenosis by TAVI
How did I treat ?
Case 2 - Moderate aortic stenosis with heart failure
Moderate aortic stenosis - Current evidence and ongoing trials
How did I treat?
Case 3 - A patient with severe aortic regurgitation to be treated by TAVI
Aortic regurgitation - Indications for intervention and emerging transcatheter technologies
How did I treat?

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Emerging indications for TAVI in 2025

Learning Objectives

Log in or create account for free